Recent research on high school and college football players highlighted that biomarkers in the blood might have potential use in spotting which players are more probable to require a longer recovery time following a concussion. Timothy B. Meier, Ph.D., Medical College of Wisconsin, Milwaukee, is the lead author of this study. He also works as a member of the American Academy of Neurology. The latest study is published in the journal Neurology.
Meier proclaimed that there are numerous individuals sustaining concussions. He added that a considerable number of these individuals witness prolonged signs and recovery. It would be very useful if tools are developed to assist determine who would be at greater risk of issues. Meier proclaimed that these research results can be considered as a critical first step. The research involved about 41 high school and college football players. During the season, these players witnessed a concussion.
On a similar note, Alzheimer’s disease starts changing the brain long before it impacts an individual’s thinking and memory. So, at present, researchers are developing various tests to find these changes in the brain. According to scientists, the list of changes includes growth in toxic proteins, inflammation, and damage to the connections between brain cells.
The tests depend on biomarkers that indicate steps toward the development of the disease. These latest tests are already engaged in making Alzheimer’s diagnosis more precise. They are also helping pharmaceutical companies test novel drugs. Maria Carrillo, Chief Science Officer, Alzheimer’s Association, proclaimed that in the upcoming period researchers will be able to employ these biomarkers to prevent or delay the memory alterations from ever happening. In 2012, the Food and Drug Administration had approved the foremost Alzheimer’s biomarker test. It is a dye named Amyvid that highlights clusters of a protein called amyloid. According to scientists, these amyloid plaques work as a hallmark of Alzheimer’s.